Alendronate-Anionic Clay Nanohybrid for Enhanced Osteogenic Proliferation and Differentiation

BACKGROUND: Alendronate (AL), a drug for inhibiting osteoclast-mediated bone-resorption, was intercalated into an inorganic drug delivery nanovehicle, layered double hydroxide (LDH), to form a new nanohybrid, AL-LDH, with 1:1 heterostructure along the crystallographic C-axis. Based on the intercalat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Korean Med Sci
Autors principals: Piao, Huiyan, Kim, Myung Hun, Cui, Meiling, Choi, Goeun, Choy, Jin-Ho
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Medical Sciences 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6356027/
https://ncbi.nlm.nih.gov/pubmed/30718990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2019.34.e37
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars